Thermo Fisher Scientific Inc.
TMO
$424.42
-$2.24-0.53%
NYSE
| 12/31/2024 | 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 11.40B | 10.60B | 10.54B | 10.35B | 10.89B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.40B | 10.60B | 10.54B | 10.35B | 10.89B |
| Cost of Revenue | 6.55B | 6.26B | 6.19B | 6.13B | 6.47B |
| Gross Profit | 4.84B | 4.34B | 4.35B | 4.22B | 4.42B |
| SG&A Expenses | 2.18B | 2.08B | 2.18B | 2.16B | 2.10B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 30.00M | -- | -- | -- | 1.00M |
| Total Operating Expenses | 9.13B | 8.68B | 8.71B | 8.62B | 8.90B |
| Operating Income | 2.26B | 1.91B | 1.83B | 1.73B | 1.99B |
| Income Before Tax | 1.97B | 1.73B | 1.68B | 1.61B | 1.74B |
| Income Tax Expenses | 150.00M | 99.00M | 128.00M | 281.00M | 133.00M |
| Earnings from Continuing Operations | 1.82B | 1.63B | 1.55B | 1.33B | 1.61B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 6.00M | -- | -6.00M | -4.00M | 24.00M |
| Net Income | 1.83B | 1.63B | 1.55B | 1.33B | 1.63B |
| EBIT | 2.26B | 1.91B | 1.83B | 1.73B | 1.99B |
| EBITDA | 3.01B | 2.65B | 2.63B | 2.56B | 2.83B |
| EPS Basic | 4.79 | 4.27 | 4.05 | 3.48 | 4.21 |
| Normalized Basic EPS | 3.62 | 2.96 | 2.76 | 2.72 | 3.10 |
| EPS Diluted | 4.78 | 4.25 | 4.04 | 3.46 | 4.20 |
| Normalized Diluted EPS | 3.61 | 2.94 | 2.75 | 2.70 | 3.10 |
| Average Basic Shares Outstanding | 382.00M | 382.00M | 382.00M | 382.00M | 387.00M |
| Average Diluted Shares Outstanding | 383.00M | 384.00M | 383.00M | 384.00M | 388.00M |
| Dividend Per Share | 0.39 | 0.39 | 0.39 | 0.39 | 0.35 |
| Payout Ratio | 8.14% | 9.20% | 9.63% | 10.17% | 8.34% |